"Vaccinia virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
| Descriptor ID |
D014616
|
| MeSH Number(s) |
B04.280.650.160.650.900
|
| Concept/Terms |
Rabbitpox virus- Rabbitpox virus
- Rabbitpox viruses
- Rabbit Pox Virus
- Rabbit Pox Viruses
Buffalopox virus- Buffalopox virus
- Buffalopox viruses
- virus, Buffalopox
- Buffalo Pox Virus
- Buffalo Pox Viruses
- Virus, Buffalo Pox
- Viruses, Buffalo Pox
|
Below are MeSH descriptors whose meaning is more general than "Vaccinia virus".
Below are MeSH descriptors whose meaning is more specific than "Vaccinia virus".
This graph shows the total number of publications written about "Vaccinia virus" by people in this website by year, and whether "Vaccinia virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 5 | 6 |
| 2006 | 5 | 0 | 5 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 3 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 2 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccinia virus" by people in Profiles.
-
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma. Cancer. 2024 Nov 15; 130(22):3845-3854.
-
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses. J Infect Dis. 2021 10 28; 224(8):1372-1382.
-
Identification of protective T-cell antigens for smallpox vaccines. Cytotherapy. 2020 11; 22(11):642-652.
-
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine. J Clin Invest. 2019 04 15; 129(5):1836-1838.
-
Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8. J Biol Chem. 2018 01 05; 293(1):390-401.
-
Oncolytic viral therapy for pancreatic cancer. J Surg Oncol. 2017 Jul; 116(1):94-103.
-
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. Vaccine. 2017 03 23; 35(13):1675-1682.
-
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. 2016 Oct 20; 167(3):684-694.e9.
-
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients. Mol Ther. 2015 Mar; 23(3):602-8.
-
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802. Eur Urol. 2015 Sep; 68(3):365-71.